Grace Therapeutics Operating Expenses Growth & History (GRCE)

Grace Therapeutics's operating expenses was $11.1M for fiscal 2026.

View full Grace Therapeutics company overview

Grace Therapeutics annual operating expenses history

Grace Therapeutics annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20262026-03-31$11.1M−$5.6M−33.59%
20252025-03-31$16.7M$5.3M+46.73%
20242024-03-31$11.4M−$6.9M−37.70%
20232023-03-31$18.2M$2.7M+17.05%
20222022-03-31$15.6M−$950,000−5.74%
20212021-03-31$16.5M

Grace Therapeutics operating expenses trends

Over the last five fiscal years, Grace Therapeutics's operating expenses decreased from $16.5M to $11.1M, a change of −$5.5M. The latest reported quarter, Q1 2027, shows $2.4M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Grace Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about GRCE yet. Start the conversation.

Write the first post